ArticleTranslational oncology2026

Dinutuximab beta with TEMIRI chemotherapy in relapsed/refractory neuroblastoma: Real-world insights into the open question of GD2 expression.

Maria Antonietta De Ioris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.